CT引导下脊神经周围注射复方倍他米松治疗腰根性神经痛  被引量:18

Periradicular compound betamethasone injection therapy for lumbar radicular pain performed under CT guidance

在线阅读下载全文

作  者:吴春根[1] 李明华[1] 程永德[2] 顾一峰[1] 谢添智[1] 宋国平[1] 丁月根[1] 

机构地区:[1]上海交通大学附属第六人民医院放射科,200233 [2]解放军南京军区介入放射中心解放军八五医院放射科

出  处:《介入放射学杂志》2006年第12期735-737,共3页Journal of Interventional Radiology

基  金:"上海市优秀青年医学人才"培养计划资金资助项目

摘  要:目的探讨CT引导下背根神经节周围注射复方倍他米松治疗腰根性神经痛临床疗效。方法在多层螺旋CT导引下注射复方倍他米松,治疗76例腰根性神经痛患者,腰椎间盘突出组31例,腰椎退行性变组45例。于术后1周和3个月随访,比较总体和两组治疗前后的视觉模拟量表(VAS)评分,分析疗效。结果78例中69例(88%)疼痛明显缓解,术前平均VAS评分为6.5±2.0。术后1周平均为3.4±1.8,术后3个月平均为3.8±1.9,术前与术后2次随访结果比较,得分差异有统计学意义,术后1周和3个月的得分差异无统计学意义。椎间盘突出组与腰椎退行性变组的得分差异也无统计学意义。结论CT导引下脊神经周围注射复方倍他米松是一种安全、有效的治疗腰根性神经痛方法。Objective To evaluate the clinical efficacy of periradicular compound betamethasone injections into the periganglionic space in the treatment of radicular pain. Methods Periganglionic compound betamethasone infiltrations were performed in 76 patients with lumbar radicular pain under MSCT guidance. All patients were divided into two groups including group 1 (31 cases of lumbar disc herniation)and group 2(45 cases of lumbar degenerative disorders). The total and two groups scores of VAS were compared after the therapeutic procedure with evaluation of the efficacy. Results 88%(69/76)of patients showed significant pain reduction, with the score of VAS 6.5 ± 2.0(before therapy)dropping to 3.4 ± 1.8(after 1 week)and 3.8 ± 1.9(after 3 month). Differences in improvements before and after the therapy were statistically significant. Differences between one-week and three-month follow-up were not statistically significant. Differences between the two groups demonstrated no statistical significance. Conclusion Periradicular compound betamethasone injection under CT guidance is safe and useful in the treatment of lumbar radicular pain.

关 键 词:脊柱疾病 复方倍他米松注射液 体层摄影术 X线计算机 

分 类 号:R681.5[医药卫生—骨科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象